Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Kruppel-like factor 9 messenger RNA 3' untranslated region (KLF9 mRNA 3′-UTR) is a critical regulatory segment of the messenger RNA encoding Kruppel-like factor 9 (KLF9), a zinc-finger transcription factor involved in cell differentiation, proliferation, and stress responses. This region serves as a primary site for post-transcriptional control, where various microRNAs (miRNAs) and RNA-binding proteins bind to modulate mRNA stability and translation efficiency. In many cancers, such as gastric and lung cancer, the KLF9 3′-UTR is targeted by oncogenic miRNAs (e.g., miR-141, miR-378), leading to the downregulation of KLF9 and subsequent promotion of tumor growth and metastasis. Conversely, in inflammatory conditions like chronic obstructive pulmonary disease (COPD), KLF9 expression is often elevated, contributing to pathological signaling through the miR-494-3p/PTEN axis. Therapeutic strategies targeting this region include the use of miRNA mimics to suppress KLF9 in overexpressed states or antagomirs and antisense oligonucleotides (ASOs) to restore KLF9 levels in deficient states. Understanding the complex regulatory network centered on the KLF9 3′-UTR is essential for developing precision RNA-based therapies for oncology and regenerative medicine.
Modulation of KLF9 protein expression through miRNA-mediated translational repression, mRNA degradation, RNA interference (RNAi), or steric hindrance of regulatory elements within the 3'-untranslated region.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kruppel-like factor 9 messenger RNA 3' untranslated region (KLF9 mRNA 3′-UTR).